SEC Form 4 · accession 0001209191-19-018293
Cidara Therapeutics, Inc. · CDTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Paul Daruwala
Officer — Chief Operating Officer
Period of report
Mar 7, 2019
Accepted (ET)
Mar 8, 2019 · 7:29 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001610618
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 7, 2019 | S | 2,240 | $2.5507 | D | 49,567 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were sold to cover the tax obligation that occurred upon the vesting of restricted stock units.